MedTrace Logo

Carbetocin Versus Oxytocin Plus Sublingual Misoprostol in the Management of Atonic Postpartum Hemorrhage

NCT03870503 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 135

Last updated 2021-09-29

No results posted yet for this study

Summary

The objective of this study is to compare the effectiveness and safety of carbetocin vs. oxytocin plus sublingual misoprostol in the management of atonic postpartum hemorrhage (PPH)after vaginal delivery.

Conditions

  • Postpartum Hemorrhage

Interventions

DRUG

oxytocin

The patient will be received oxytocin 20 IU by intravenous infusion

DRUG

oxytocin plus misoprostol

The patient will be received oxytocin 20 IU by intravenous infusion plus 400 mic gm sublingual misoprostol

DRUG

Carbetocin

The patient received Carbetocin 100 mic gm

Sponsors & Collaborators

  • Aswan University Hospital

    lead OTHER

Principal Investigators

  • hany f allam, md · Aswan University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2021-06-30
Completion
2021-08-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03870503 on ClinicalTrials.gov